Reversible Quantum Dot-Driven Multiplex Technology for In Situ Subcellular Structure Imaging

Area of Science:

• * Nanotechnology and Molecular Biology
• * Cellular Imaging and Diagnostics

Background:

• * Traditional immunofluorescence methods struggle with signal quenching, limited throughput, and complex antibody modification.
• * Existing techniques hinder detailed organelle analysis and multiplexed imaging.

Purpose of the Study:

• * To introduce ssDNA-quantum dot imaging encoding (ssQIE) as an improved in situ imaging technique.
• * To address limitations in antibody modification and fluorescence channel constraints.
• * To enable advanced organelle imaging and analysis, particularly in disease states like ferroptosis.

Main Methods:

• * Development of ssQIE, combining quantum dots with DNA nanotechnology for antibody labeling.
• * Utilizing ssDNA-modified antibodies and quantum dot-DNA complexes for signal capture.
• * Comparative analysis of ssQIE against conventional immunofluorescence and CODEX methods.

Main Results:

• * ssQIE demonstrated signal amplification and multiplexing capabilities with single-channel excitation.
• * The method proved effective for multiple rounds of cyclic imaging under mild conditions.
• * Quantum dot optical properties ensured high-quality imaging performance.

Conclusions:

• * ssQIE offers a breakthrough solution for antibody modification and fluorescence channel limitations.
• * The technique enables detailed in situ imaging and analysis of organelles, including their role in ferroptosis.
• * ssQIE highlights the potential of integrating quantum dots and DNA nanotechnology for advanced biological imaging.